IRIS
PORRECA, Ettore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.721
EU - Europa 4.794
AS - Asia 2.594
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 9
AF - Africa 6
SA - Sud America 5
Totale 13.141
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.695
CN - Cina 992
UA - Ucraina 923
IE - Irlanda 894
SE - Svezia 758
SG - Singapore 713
TR - Turchia 622
IT - Italia 583
GB - Regno Unito 514
FR - Francia 340
DE - Germania 328
FI - Finlandia 190
IN - India 184
RU - Federazione Russa 162
BE - Belgio 31
CA - Canada 23
TW - Taiwan 22
CZ - Repubblica Ceca 14
VN - Vietnam 14
EU - Europa 11
PL - Polonia 10
AU - Australia 8
GR - Grecia 8
KR - Corea 8
NL - Olanda 8
IL - Israele 7
IR - Iran 7
HK - Hong Kong 6
RO - Romania 6
ES - Italia 5
TH - Thailandia 5
AT - Austria 4
ID - Indonesia 4
JP - Giappone 4
BR - Brasile 3
KE - Kenya 3
BD - Bangladesh 2
DK - Danimarca 2
EE - Estonia 2
EG - Egitto 2
HR - Croazia 2
MX - Messico 2
NO - Norvegia 2
RS - Serbia 2
SR - Suriname 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
CH - Svizzera 1
HU - Ungheria 1
IQ - Iraq 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
ZA - Sudafrica 1
Totale 13.141
Salva come PNG Salva come JPEG
Città #
Chandler 1.106
Jacksonville 1.058
Dublin 879
Singapore 615
Princeton 443
Southend 391
Izmir 331
Nanjing 295
Dearborn 250
Wilmington 224
Cambridge 173
Santa Clara 169
Ashburn 165
Beijing 154
Altamura 141
Ann Arbor 131
Chieti 125
Nanchang 99
Boardman 81
Woodbridge 80
Hebei 66
Shenyang 54
Kunming 47
Jiaxing 45
Los Angeles 45
Tianjin 41
New York 35
Helsinki 34
Grevenbroich 33
Washington 33
Brussels 29
Changsha 28
Hangzhou 28
San Mateo 27
Norwalk 26
Houston 25
Falls Church 24
Munich 24
Pescara 24
Jinan 20
Leawood 20
Seattle 20
Augusta 18
Orange 17
Guangzhou 15
Dong Ket 14
Ningbo 14
Toronto 14
Auburn Hills 12
Hefei 12
Kocaeli 12
Taipei 11
Teramo 11
Hanover 10
Kraków 10
Lanzhou 10
Changchun 9
Moscow 9
Bellante 8
Brno 8
Edinburgh 8
Montenero Di Bisaccia 8
Rome 8
Zhengzhou 8
Cologno Monzese 7
Monmouth Junction 7
San Giovanni 7
Sant'onofrio 7
Taizhou 7
Vasto 7
Ardabil 6
Pianella 6
Sydney 6
Tappahannock 6
Bangkok 5
Buffalo 5
Olomouc 5
Pune 5
Rochester 5
Altino 4
Fuzhou 4
Hong Kong 4
Mcallen 4
Milan 4
Montesilvano Marina 4
New Taipei 4
Paris 4
Plymouth 4
Redmond 4
Redwood City 4
Trieste 4
Amsterdam 3
Andover 3
Bangalore 3
Düsseldorf 3
Gangbuk-gu 3
Haikou 3
Iglesias 3
Loreto Aprutino 3
Madrid 3
Totale 8.050
Salva come PNG Salva come JPEG
Nome #
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study 194
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 113
Effect of MK-571, a selective leukotriene D4 receptor antagonist, on vascular smooth muscle cell proliferation and interleukin 1 release 109
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 108
Reduced variability to aspirin antiplatelet effect by the coadministration of statins in high-risk patients for cardiovascular disease. 107
48-Hour continuous pH measurement in patients with gastro-oesophageal reflux: effect of cisapride. 101
Pravastatin upregulates TGF-b1 in THP-1 human macrophage: effect on scavenger receptor class A expression. 99
Aortic antioxidant defence mechanisms: time-related changes in cholesterol-fed rabbits. 98
Increased expression of transforming growth factor beta isoforms by human monocytes of hypertensive patients 98
Ambulatory Blood Pressure Parameters and Heart Failure With Reduced or Preserved Ejection Fraction in Elderly Treated Hypertensive Patients 95
INCREASED TYPE I AND TYPEII TRANSFORMING GROWTH FACTOR-β RECEPTOR EXPRESSION DURING CHOLESTEROL CHALLENGE. 94
Angiotensin-converting enzyme inhibitors counteract hypoxia-induced coronary constriction in the isolated rat heart 94
Reversal of P-glycoprotein-mediated multidrug resi stance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs 94
Impaired enzymatic reactive aldehyde-detoxifying capacity and glutathione peroxidase activity in the aged human arterial tissue 94
Cholesterol feeding modulates type I and type II TGF-beta receptor expression and fibrogenic vascular remodelling in C57BL/6 mice (pubbl. su Atherosc.) 93
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 92
Haemostatic abnormalities, cardiac involvement and serum tumor necrosis factor levels in X-linked dystrophic patients. 91
Combined effect of glucose and insulin in stimulating plasminogen activator inhibitor-1 secretion and gene expression in human vascular smooth muscle cells in culture 90
Apixaban for extended treatment of venous thromboembolism 89
Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese patients. 88
Human interleukin 1 receptor antagonist (IL-1RA) inhibition of inducible thromboxane B2 generation in human monocytes 88
Antioxidant metabolic mechanisms in hypertensive and atherosclerotic arterial wall 87
ISOXAZOLE DERIVATIVES AND THEIR USE AS CYCLOOXYGENASE INHIBITORS 86
AORTIC ANTIOXIDANT DEFENSE MECHANISMS IN RABBITS SUBJECTED TO SUPRARENAL AORTIC COARCTATION HYPERTENSION 86
Prognostic value of nondipping and morning surge in elderly treated hypertensive patients with controlled ambulatory blood pressure 86
Circadian variations in antioxidant defences and lipid peroxidation in the rat heart 85
Microsatellite polymorphism of the human leptin gene (LEP) and risk of cardiovascular disease 85
Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy. 85
Oral apixaban for the treatment of acute venous thromboembolism 84
Study of the gastric mucosal reactivity in patients with urticaria induced by nonsteroidal anti-inflammatory drugs. 83
Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review 83
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism 83
Synergic effect of glucose and insulin in stimulating plasminogen activator inhibitor 1 (PAI-1) expression and secretion in human vascular smooth cells (vSMC) 82
Increased type II transforming growth factor-beta receptor expression in liver cells during cholesterol challenge 82
Effect of interleukin-1 receptor antagonist (IL-1RA) on vascular smooth muscle cell proliferation (VSMC). 82
Circulating leptin is associated with oxidized LDL in postmenopausal women. 82
Antioxidant metabolic mechanisms in hypertensive and atherosclerotic arterial wall 82
Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. 81
Transforming growth factor beta1 induces IL-1 receptor antagonist production and gene expression in rat vascular smooth muscle cells 81
Morning Blood Pressure Surge, Dipping, and Risk of Coronary Events in Elderly Treated Hypertensive Patients 81
Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo. 80
PRAVASTATIN UP-REGULATES TGF-B1 IN THP-1 HUMAN MACROPHAGES :EFFECT ON SCAVENGER RECEPTOR CLASS A EXPRESSION 79
New method for the extraction of DNA from white blood cells for the detection of common genetic variants associated with thrombophilia 79
The hematocrit and platelet target in polycytemia vera 79
CYCLOOXYGENASE-2-DERIVED PROSTACYCLIN RESTRAIN PLATELET THROMBOXANE BIOSYNTHESIS IN TOLL-LIKE RECEPTOR 4 POLYMORPHISM 79
Metabolic Syndrome and Cardiovascular Risk in Elderly Treated Hypertensive Patients. 79
Transforming growth factor beta1 induces IL-1 receptor antagonist gene expression and production in rat vascular smooth muscle cells 78
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 78
Iron status and oxidative stress in the aged rabbit heart 78
Rivaroxaban or aspirin for extended treatment of venous thromboembolism 78
Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis 78
Increased Plasminogen Activator Inhibitor (PAI-1) Synthesis and Gene Expression in Adipocyte of Diabetic Rats 77
Down regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes. 77
Identification of three genetic risk factors for venous thrombosis using a multiplex allele-specific PCR assay: comparison of conventional and new alternative methods for the preparation of DNA from clinical samples 77
Modulatory effects of heparin on cellular accumulation and cytotoxicity of doxorubicin in MRP1-overexpressing HL60/doxo cells. 77
Myocardial antioxidant defence mechanisms: time-related changes after reperfusion of the ischemic rat heart 77
The effect of the plasticizer diethylhexyl phthalate on transport activity and expression of P-glycoprotein in parental and doxo-resistant human sarcoma cell lines. 77
Oral rivaroxaban for symptomatic venous thromboembolism 77
Determinants of platelet activation in Alzheimer's disease 77
Aortic antioxidant defence mechanisms during the progression of atherosclerosis in cholesterol-fed rabbits 76
Circadian blood pressure changes and cardiovascular risk in elderly-treated hypertensive patients 76
Dementia in patients with atrial fibrillation and the value of the Hachinski ischemic score 76
Effects of multiple inherited and acquired thrombophilia on outcomes of in-vitro fertilization 76
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 76
Monocyte chemoattractant protein-1 as a mitogen for vascular smooth muscle cell 75
Protein kinase C pathway and proliferative response of aged and young rat vascular smooth muscle cell. 75
Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients. 75
Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. 75
Antiproliferative effect of deferoxamine on vascular muscle cells in vitro and in vivo. 75
Antioxidant properties of ticlopidine on human low density lipoprotein oxidation 75
Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis 74
Rivaroxaban for cancer-associated cardiac thrombosis 74
Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis 74
Association of Factor VII Levels With Inflammatory Parameters in Hypercholesterolemic Patients. 73
Trasforming growth factor-beta 1 levels in hypertensive patients: association with body mass index and leptin. 73
Prognosis of Masked and White Coat Uncontrolled Hypertension Detected by Ambulatory Blood Pressure Monitoring in Elderly Treated Hypertensive Patients 73
Regional distribution of glutathione-related antioxidant defences in the normal rabbit aorta. 72
Glutathione-related enzyme activities and lipoperoxide levels in human internal mammary artery and ascending aorta. Relations with serum lipids 71
Non-O blood group and outcomes of in vitro fertilization 71
Induction of alkaline phosphatase generation by IL-1ß and LPS on human neutrophils and macrophages and lack of inhibition by interleukin-1 receptor antagonist. 70
Time course of aortic antioxidant defense mechanisms in rabbit experimental atherosclerosis 70
Systemic oxidative stress status in patients with ischemic heart disease 70
Cysteinyl-leukotriene D4 induced IL-1 beta expression ans release in rat vascular smooth muscle cells. 70
Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients 70
“ISOXAZOLE DERIVATIVES AND THEIR USE AS CYCLOOXYGENASE INHIBITORS" 69
Infra-red laser irradiation enhances interleukin-1 receptor antagonist, increase 3H-thymidine incorporation and the release of 3H arachidonic acid in human macrophages 69
Increased phosphatidylserine exposure on platelets from hospitalized patients with acute medical illnesses 69
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 69
Vascular changes in hypertensive patients with different left ventricular geometry 68
Vascular non-protein thiols: prooxidants or antioxidants in atherogenesis? 68
IS THE SIMPLEST EXPLANATION USUALLY THE CORRECT ONE? A CLINICAL APPLICATION OF THE "OCKHAM'S RAZOR" 68
Increased transforming growth factor-beta production and gene expression by peripheral blood monocytes of hypertensive patients. 67
EFFECTS OF NABUMETONE AND ITS ACTIVE METABOLITE 6-METHOXY-2-NAPHTHYL ACETIC ACID ON HUMAN BLOOD PROSTAGLANDIN H SYNTHASES. 67
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy. 67
Transforming growth factor-β1 levels in hypertensive patients: association with body mass index and leptin 67
Modulation of aspirin-insensitive eicosanoid biosynthesis by 6-methylprednisolone in unstable angina. 66
Effect of aortic coarctation hypertension on the antioxidant defense mechanisms in the rabbit aorta 66
Effect of high fat-, cholesterol-enriched diet on the antioxidant defence mechanisms in the rabbit heart 66
Human recombinant interleukin-1 beta induces thromboxane A2 release in polymorphonuclear leukocytes, macrophages and platelets: effect of IL-1 receptor antagonist. 66
Transforming growth factor-beta 1 levels in hypertensive patients: association with body mass index and leptin. 66
Totale 8.109
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.505
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.505
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.502 0 0 25 82 185 188 327 216 72 150 235 22
2020/20211.291 174 15 225 26 106 271 15 20 100 166 79 94
2021/20221.035 53 14 11 237 78 24 25 82 68 17 103 323
2022/20233.120 264 406 180 335 304 635 177 227 406 39 88 59
2023/20241.375 94 48 124 45 108 393 299 55 31 38 7 133
2024/20251.387 245 633 509 0 0 0 0 0 0 0 0 0
Totale 13.699